Showing results (61-70 of 226) with videos related to
Sort By:
Pageof 23
Critical Care Clinics|May 22, 2026
The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial VirusDaniel Anthony Sweeney, Xavier Wittebole, Andre Celestino KalilExpert Review of Anti-Infective Therapy|October 28, 2011
Immunomodulatory therapy for sepsis: an updateEirini Christaki, Panagiota Anyfanti, Steven M OpalCurrent Opinion in Infectious Diseases|February 14, 2012
Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis?Eirini Christaki, Nikolaos Lazaridis, Steven M OpalThe Lancet. Infectious Diseases|December 8, 2007
Host-pathogen interactions in sepsisTom van der Poll, Steven M OpalAnnals of Translational Medicine|October 8, 2016
The role of genetics and antibodies in sepsisEvangelos J Giamarellos-Bourboulis, Steven M OpalLancet (London, England)|November 3, 2009
Pathogenesis, treatment, and prevention of pneumococcal pneumoniaTom van der Poll, Steven M OpalIndian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|March 27, 2015
Fatal lactic acidosis possibly related to ganciclovir therapy in a renal transplant patient?Xavier Wittebole, Johann Morelle, Marie-Françoise Vincent, et al.Intensive Care Medicine|May 19, 2004
Coagulation in sepsisAndré Amaral, Steven M Opal, Jean-Louis VincentClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2005
Insights into severe sepsis in older patients: from epidemiology to evidence-based managementTimothy D Girard, Steven M Opal, E Wesley ElyCritical Care Medicine|September 5, 2009
Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisionsJean-Louis Vincent, Steven M Opal, John C MarshallPageof 23